Edition:
United Kingdom

Conmed Corp (CNMD.OQ)

CNMD.OQ on NASDAQ Stock Exchange Global Select Market

99.29USD
23 Aug 2019
Change (% chg)

$-1.66 (-1.64%)
Prev Close
$100.95
Open
$100.66
Day's High
$101.66
Day's Low
$99.09
Volume
94,995
Avg. Vol
86,338
52-wk High
$102.41
52-wk Low
$57.38

Latest Key Developments (Source: Significant Developments)

Conmed Corp Announces Second Quarter Earnings Per Share Of $0.19
Wednesday, 31 Jul 2019 

July 31 (Reuters) - Conmed Corp ::ANNOUNCES SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.56.Q2 GAAP EARNINGS PER SHARE $0.19.SEES FY 2019 SALES ABOUT $951 MILLION TO $958 MILLION.Q2 SALES $238.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $233.3 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.53 -- REFINITIV IBES DATA.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $2.52 TO $2.57.FY2019 EARNINGS PER SHARE VIEW $2.48, REVENUE VIEW $945.7 MILLION -- REFINITIV IBES DATA.  Full Article

Conmed Corporation Q1 GAAP Earnings Per Share $0.04
Wednesday, 24 Apr 2019 

April 24 (Reuters) - Conmed Corp ::ORATION ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $0.57.Q1 GAAP EARNINGS PER SHARE $0.04.Q1 SALES $218.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF $213.1 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.54 -- REFINITIV IBES DATA.SEES FY 2019 SALES UP 9 TO 10 PERCENT.NEGATIVE IMPACT TO 2019 SALES FROM FOREIGN EXCHANGE IS NOW EXPECTED TO BE ABOUT 75 BASIS POINTS.COMPANY INCREASING ITS FY 2019 GUIDANCE FOR ADJUSTED DILUTED NET EARNINGS PER SHARE TO RANGE OF $2.47 TO $2.52 FROM ORIGINAL RANGE OF $2.42 TO $2.47.  Full Article

Conmed Q4 Adjusted Earnings Per Share $0.73
Tuesday, 22 Jan 2019 

Conmed Corp ::ORATION ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2018 FINANCIAL RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $0.73.Q4 GAAP EARNINGS PER SHARE $0.54.Q4 SALES $242.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF $228.8 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $0.72 -- REFINITIV IBES DATA.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $2.42 TO $2.47.NEGATIVE IMPACT TO 2019 SALES FROM FOREIGN EXCHANGE IS ANTICIPATED TO BE APPROXIMATELY 100 BASIS POINTS..EXPECTS FULL-YEAR 2019 CONSTANT-CURRENCY SALES GROWTH IN RANGE OF 5.0% TO 6.0%.  Full Article

Conmed Q4 Earnings Per Share $1.65
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Conmed Corp ::ORATION ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $2.11 TO $2.17.Q4 GAAP EARNINGS PER SHARE $1.65.Q4 EARNINGS PER SHARE VIEW $0.63 -- THOMSON REUTERS I/B/E/S.Q4 ADJUSTED EARNINGS PER SHARE $0.69.Q4 SALES $222.6 MILLION VERSUS I/B/E/S VIEW $211.3 MILLION.EXPECTS FULL-YEAR 2018 CONSTANT CURRENCY SALES GROWTH IN 4.0% TO 5.0% RANGE.  Full Article

Conmed Corp announces retirement of CFO ‍Luke A. Pomilio
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Conmed Corp :Conmed Corp announces retirement of chief financial officer.Conmed Corp - ‍Luke A. Pomilio, executive vice president, finance and chief financial officer, has decided to retire​.Conmed Corp - ‍company has initiated a search for a new CFO​.  Full Article

Conmed Corp reports Q3 adjusted earnings per share $0.42
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Conmed Corp :Conmed Corp announces third quarter 2017 financial results.Q3 adjusted earnings per share $0.42.Q3 sales $190.1 million versus I/B/E/S view $187.1 million.Q3 earnings per share view $0.41 -- Thomson Reuters I/B/E/S.Q3 GAAP earnings per share $0.26.Conmed Corp - ‍expects 2017 constant currency sales growth in range of 2.50% to 3.25%​.Conmed Corp - ‍expects 2017 adjusted diluted net earnings per share in range of $1.85 to $1.90​.Fy2017 earnings per share view $1.87, revenue view $780.4 million -- Thomson Reuters I/B/E/S.  Full Article